glp-1 effectiveness Receptor Agonists as Treatments for Type 2 Diabetes How GLP-1 Medications Boost Weight

Am J Med (2010) 123:468

Aims The aim of this study was to describe experiences of self-administering GLP-1 receptor agonists and its perceived impact on mental health in patients with obesity and/or T2D

Cmaj , 185 (4), pp.309-316

Warning Letters to Telehealth providers marketing GLP-1 compounded On March 3rd, FDA sent multiple sets of warnings to 30 Telehealth companies offering GLP-1s on their websites warning them to refrain from improperly using a brand when they are not the compounder or claiming equivalency to FDA approved drugs

Individual costs will still depend on insurance and available savings programs

However, the degree of appetite suppression may vary from person to person, and some individuals may start feeling the effects sooner than others